form 4 Form 4 — FPN General Partner LLC 2026-03-02 View Filing form 4 Form 4 — Flagship Pioneering Fund VI General Partner LLC 2026-03-02 View Filing form 4 Form 4 — Flagship VentureLabs VI Manager ...

Agoyu integrated its AI moving quote tool into select Realtor.com rental and for-sale listings. Users record a short video of belongings, and the AI estimates weight and volume to deliver real time ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon of ...

Generate Biomedicines, Inc. is a clinical-stage biotechnology company focused on using artificial intelligence and machine learning to create protein-based medicines. The company operates in the ...

Tuesday might not be your favorite day of the week, but it has its merits. For one thing, SmartRecruiters says Tuesday is not only the most productive day of the week, but it’s also the best day for ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

Rebar, a startup building an AI operating system for commercial HVAC suppliers, has raised $14 million in a Series A funding round, it tells Crunchbase News exclusively. Founded in October 2024, Rebar ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...